Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The immaturity of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a major limitation for their use in drug screening to identify pro-arrhythmogenic or cardiotoxic molecules. Here, we demonstrate an approach that combines lipid-enriched maturation medium with a high concentration of calcium, nanopatterning of culture surfaces and electrostimulation to generate iPSC-CMs with advanced electrophysiological, structural and metabolic phenotypes. Systematic testing reveals that electrostimulation is the key driver of enhanced mitochondrial development and metabolic maturation and improved electrophysiological properties of iPSC-CMs. Increased calcium concentration strongly promotes electrophysiological maturation, while nanopatterning primarily facilitates sarcomere organisation with minor effect on electrophysiological properties. Transcriptome analysis reveals that activation of HMCES and TFAM targets contributes to mitochondrial development, whereas downregulation of MAPK/PI3K and SRF targets is associated with iPSC-CM polyploidy. These findings provide mechanistic insights into iPSC-CM maturation, paving the way for pharmacological responses that more closely resemble those of adult CMs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928738 | PMC |
| http://dx.doi.org/10.1038/s41467-025-58044-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Non-invasive maturity assessment of iPSC-CMs based on optical maturity characteristics using interpretable AI.
Comput Struct Biotechnol J
August 2025
Institute of Biomedical Engineering, TU Dresden, Fetscherstr. 29, Dresden 01307, Germany.
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) are an important resource for identifying novel therapeutic targets and cardioprotective drugs. However, a key limitation of iPSC-CMs is their immature, fetal-like phenotype. Cultivation of iPSC-CMs in lipid-supplemented maturation media (MM) enhances the structural, metabolic and electrophysiological properties of iPSC-CMs.
View Article and Find Full Text PDFCombine the wet and dry ingredients: Mixing experimental and computational models for a deeper understanding of stem cell-derived cardiomyocytes.
J Physiol
July 2025
Department of Pharmacological Sciences & Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Knowledge in cardiac development, heart disease and drug-induced toxicity has steadily progressed for centuries, but the most recent decades have seen an explosion in technological advancements that have benefited cardiac research. In particular, the development of induced pluripotent stem cells (iPSCs) derived from accessible human adult tissues, as well as lineage-specific cell cultures differentiated from these iPSCs, has led to the rapid growth of the iPSC-derived cardiomyocyte (iPSC-CM) as a promising in vitro model. However, major differences in iPSC-CM phenotype have been observed across studies.
View Article and Find Full Text PDFInduced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.
Int J Mol Sci
May 2025
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Cardiomyopathies are a heterogeneous group of heart muscle diseases that can lead to heart failure, arrhythmias, and sudden cardiac death. Traditional animal models and in vitro systems have limitations in replicating the complex pathology of human cardiomyopathies. Induced pluripotent stem cells (iPSCs) offer a transformative platform by enabling the generation of patient-specific cardiomyocytes, thus opening new avenues for disease modeling, drug discovery, and regenerative therapy.
View Article and Find Full Text PDFCalcium-Activated Sarcomere Contractility Drives Cardiomyocyte Maturation and the Response to External Mechanical Cues but is Dispensable for Sarcomere Formation.
bioRxiv
March 2025
Department of Cell and Molecular Physiology, Loyola University Stritch School of Medicine, Maywood, IL.
Background: Understanding the mechanisms of cardiomyocyte development is critical for fulfilling the potential of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Although myocyte development is known to depend on internal and external mechanical cues, further investigation is required to understand the contributions of different signals and how they are integrated together to generate an adult cardiomyocyte. Here, we address this gap by examining the role of calcium-activated contractility in sarcomere formation and maturation and its influence on the iPSC-CM response to nanopatterns.
View Article and Find Full Text PDFComprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation.
Nat Commun
March 2025
Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
The immaturity of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a major limitation for their use in drug screening to identify pro-arrhythmogenic or cardiotoxic molecules. Here, we demonstrate an approach that combines lipid-enriched maturation medium with a high concentration of calcium, nanopatterning of culture surfaces and electrostimulation to generate iPSC-CMs with advanced electrophysiological, structural and metabolic phenotypes. Systematic testing reveals that electrostimulation is the key driver of enhanced mitochondrial development and metabolic maturation and improved electrophysiological properties of iPSC-CMs.
View Article and Find Full Text PDF